Piperacillin/tazobactam Treatment for Severe Community-acquired Pneumonia among Elderly
- VernacularTitle:哌拉西林/他唑巴坦治疗老年重症社区获得性肺炎临床分析
- Author:
Zaichun DENG
;
Bin WAN
;
Lei CHEN
;
Baohong CHEN
;
Chengjie ZHOU
- Publication Type:Journal Article
- Keywords:
Piperacillin/tazobactam;
Ceftriaxone;
Elderly;
Severe community-aequired pneumonia
- From:
Chinese Journal of Nosocomiology
2009;0(24):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To evaluate the clinical efficacy of piperacillin/tazobactam for severe community acquired pneumonia(CAP) among elderly.METHODS Seventy-six elderly cases of severe CAP were randomized into piperacillin/tazobactam group and ceftriazone group,and the sputum culture was underwent for each case before and after treatment.RESULTS The total efficacy rates and bacterial clearance rates in piperacillin/tazobactam group and ceftriazone group were 92.11% and 88.89%,and 73.68% and 58.82%,respectively,and the differences between the two groups were statistically significant.CONCLUSIONS It suggestes that piperacillin/tazobactam be a more effective drug for severe CAP among elderly in old age.
